Health · Medical Research · 1 hr ago

Russian cancer vaccine shows early result in first patient

Russian cancer vaccine shows early result in first patient

A Russian team has reported an early result from its personalized mRNA cancer vaccine.

The vaccine, called NeoOnkovak, was first tested in April on a patient diagnosed with skin melanoma.

The team’s scientific adviser said the patient’s metastases are no longer detectable and the patient has been well for four months.

The vaccine is made separately for each patient using genetic information from their tumor, rather than following one standard formula.

The patient remains under regular medical checks, planned to continue for three years.

One patient’s result does not prove the vaccine works, and specialists say larger clinical studies and longer testing are needed.

Separately, the European Commission approved Daraxonrasib for adults with metastatic pancreatic cancer who have already received at least one treatment.

1 source

Related